Literature DB >> 22199314

The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.

Yasuhiro Chikaishi1, Hidetaka Uramoto, Fumihiro Tanaka.   

Abstract

BACKGROUND: The epithelial to mesenchymal transition (EMT) is an important contributor to the invasion and metastasis of epithelial cell-derived cancer. However, whether or not the expression of EMT-related molecules can be used as a biomarker for the prognosis of lung cancer has yet to be fully determined. PATIENTS AND METHODS: Tumor specimens were collected from 183 consecutive patients who underwent a complete resection for lung adenocarcinoma. We analyzed the E-cadherin, gamma-catenin, vimentin, and fibronectin expression levels in the primary lung adenocarcinoma by immunohistochemical analysis.
RESULTS: A positive expression of E-cadherin, gamma-catenin, vimentin, and fibronectin was observed in 94 (51.4%), 82 (40.4%), 32 (17.5%) and 1 (0.5%) patient, respectively. A significant association between E-cadherin expression and the pathological stage, T status, N status, tumor grade, and carcinoembryonic antigen was identified. The rate of gamma-catenin positivity was higher in patients with a smoking history than in never smokers. Moreover, a significant correlation was observed between vimentin expression and the pathological stage, N status, and tumor grade. However, an association between EMT-related molecules and postoperative recurrence of lung adenocarcinoma is lacking. Based on a Kaplan-Meier analysis, the expression of EMT-related molecules is not associated with the survival of lung adenocarcinoma patients.
CONCLUSION: The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung cancer patients. Our findings indicate that immunocytochemical markers related to EMT do not provide relevant prognostic information about lung adenocarcinoma. Future research is therefore expected to clarify the clinical usefulness of EMT-related molecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199314

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.

Authors:  Y Zhang; L F Wang; J H Gao; L Li; P Jiang; X Lv; L X Yu; J Yang; R T Li; B R Liu
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

Review 2.  Recurrence after surgery in patients with NSCLC.

Authors:  Hidetaka Uramoto; Fumihiro Tanaka
Journal:  Transl Lung Cancer Res       Date:  2014-08

3.  Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.

Authors:  Ioannis P Gialmanidis; Vasiliki Bravou; Ilias Petrou; Helen Kourea; Alexandros Mathioudakis; Ioannis Lilis; Helen Papadaki
Journal:  Lung       Date:  2013-07-18       Impact factor: 2.584

Review 4.  The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Authors:  Kristine Raaby Jakobsen; Christina Demuth; Boe Sandahl Sorensen; Anders Lade Nielsen
Journal:  Transl Lung Cancer Res       Date:  2016-04

5.  A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome.

Authors:  Rama Soundararajan; Anurag N Paranjape; Valentin Barsan; Jeffrey T Chang; Sendurai A Mani
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

6.  Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer.

Authors:  Fariz Nurwidya; Fumiyuki Takahashi; Akiko Murakami; Kazuhisa Takahashi
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

7.  A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC.

Authors:  Deepak Perumal; Sandeep Singh; Sean J Yoder; Gregory C Bloom; Srikumar P Chellappan
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

8.  The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.

Authors:  Xiaobo He; Ting Zhou; Guangwei Yang; Wenfeng Fang; Zelei Li; Jianhua Zhan; Yuanyuan Zhao; Zhibin Cheng; Yan Huang; Hongyun Zhao; Li Zhang
Journal:  Oncotarget       Date:  2016-03-22

9.  Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.

Authors:  Zhihua Ye; Xin Zhang; Yihuan Luo; Shikang Li; Lanshan Huang; Zuyun Li; Ping Li; Gang Chen
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

Review 10.  Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.

Authors:  Kemal Behzatoglu
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.